Intermediate of API

Benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride

CasNo:1228879-37-5

Molecular Formula:

Specifications:>0.98

(3R,4R)-1-Benzyl-N,4-dimethylpiperidin-3-amine ((2R,3R)-2,3-bis((4-methylbenzoyl)oxy)succinate) (2:1)

CasNo:477600-71-8

Molecular Formula:

Specifications:>0.98

(3R,4R)-1-Benzyl-N,4-diMethylpiperidin-3-Amine dihydrochloride

CasNo:1062580-52-2

Molecular Formula:

Specifications:>0.98

4-Chloropyrrolo[2,3-d]pyrimidine

CasNo:3680-69-1

Molecular Formula:

Specifications:>0.98

2,4-Dichloro-7H-pyrrolo[2,3-d]pyrimidine

CasNo:90213-66-4

Molecular Formula:

Specifications:>0.98

4-CHLORO-7-TOSYL-7H-PYRROLO[2,3-D]PYRIMIDINE

CasNo:479633-63-1

Molecular Formula:

Specifications:>0.98

7H-Pyrrolo[2,3-d]pyrimidin-4-amine,N-methyl-N-[(3R,4R)-4-methyl-1-(phenylmethyl)-3-piperidinyl]-7-[(4-methylphenyl)sulfonyl]​-

CasNo:923036-30-0

Molecular Formula:

Specifications:>0.98

7H-Pyrrolo[2,3-d]pyrimidin-4-amine, N-methyl-N-[(3R,4R)-4-methyl-1-(phenylmethyl)-3-piperidinyl]​-

CasNo:477600-73-0

Molecular Formula:

Specifications:>0.98

tofacitinib citrate

CasNo:540737-29-9

Molecular Formula:

Specifications:>0.98

1-(1-ethoxyethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole

CasNo:1029716-44-6

Molecular Formula:

Specifications:>0.98

4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole

CasNo:269410-08-4

Molecular Formula:

Specifications:>0.98

2-(1-(ethylsulfonyl)azetidin-3-ylidene)acetonitrile

CasNo:1187595-85-2

Molecular Formula:

Specifications:>0.98